Related Experiment Video
Updated: Jun 4, 2026

Utilizing Murine Inducible Telomerase Alleles in the Studies of Tissue Degeneration/Regeneration and Cancer
Published on: April 13, 2015
Telomerase reverse transcriptase protects ATM-deficient hematopoietic stem cells from ROS-induced apoptosis through a
Eriko Nitta1, Masayuki Yamashita, Kentaro Hosokawa
1Department of Cell Differentiation, The Sakaguchi Laboratory of Developmental Biology, Keio University School of Medicine, Tokyo, Japan.
Abstract:
Telomerase reverse transcriptase (TERT) contributes to the prevention of aging by a largely unknown mechanism that is unrelated to telomere lengthening. The current study used ataxia-telangiectasia mutated (ATM) and TERT doubly deficient mice to evaluate the contributions of 2 aging-regulating molecules, TERT and ATM, to the aging process. ATM and TERT doubly deficient mice demonstrated increased progression of aging and had shorter lifespans than ATM-null mice, while TERT alone was insufficient to affect lifespan. ATM-TERT doubly null mice show in vivo senescence, especially in hematopoietic tissues, that was dependent on p16(INK4a) and p19(ARF), but not on p21. As their HSCs show decreased stem cell activities, accelerated aging seen in these mice has been attributed to impaired stem cell function. TERT-deficient HSCs are characterized by reactive oxygen species (ROS) fragility, which has been suggested to cause stem cell impairment during aging, and apoptotic HSCs are markedly increased in these mice. p38MAPK activation was indicated to be partially involved in ROS-induced apoptosis in TERT-null HSCs, and BCL-2 is suggested to provide a part of the protective mechanisms of HSCs by TERT. The current study demonstrates that TERT mitigates aging by protecting HSCs under stressful conditions through telomere length-independent mechanisms.
Insights
Telomerase reverse transcriptase (TERT) protects hematopoietic stem cells (HSCs) from aging through a telomere-independent mechanism. This study shows TERT mitigates aging by safeguarding HSCs under stress, preventing premature senescence and extending lifespan.
Area of Science:
- Gerontology
- Molecular Biology
- Hematology
Background:
- Telomerase reverse transcriptase (TERT) is implicated in aging, but its precise role, independent of telomere lengthening, remains unclear.
- Ataxia-telangiectasia mutated (ATM) is another key regulator of aging.
- Understanding the interplay between TERT, ATM, and aging is crucial for developing interventions.
Purpose of the Study:
- To investigate the combined roles of ATM and TERT in the aging process using a mouse model.
- To elucidate the mechanisms by which TERT influences aging, particularly in hematopoietic stem cells (HSCs).
- To determine if TERT's anti-aging effects are dependent on telomere length.
Main Methods:
- Utilized ATM and TERT doubly deficient mice to assess aging phenotypes and lifespan.
- Analyzed in vivo senescence markers, including p16(INK4a), p19(ARF), and p21.
- Examined hematopoietic stem cell (HSC) function, reactive oxygen species (ROS) levels, apoptosis, and associated signaling pathways (p38MAPK, BCL-2).
Main Results:
- ATM and TERT doubly deficient mice exhibited accelerated aging and reduced lifespan compared to ATM-null mice.
- Accelerated aging was linked to in vivo senescence in hematopoietic tissues, dependent on p16(INK4a) and p19(ARF).
- TERT deficiency in HSCs led to ROS fragility, increased apoptosis, and impaired stem cell function, suggesting a critical role for TERT in HSC protection.
Conclusions:
- TERT mitigates aging by protecting HSCs from stress-induced damage via telomere length-independent mechanisms.
- TERT's protective role in HSCs involves managing ROS and preventing apoptosis, partly through p38MAPK and BCL-2 pathways.
- ATM and TERT act synergistically in regulating the aging process, with TERT playing a vital role in maintaining stem cell integrity.
Related Concept Videos
Telomeres and Telomerase
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Replicative Cell Senescence
Regulation of Hematopoietic Stem Cells
Multipotency of Hematopoietic Stem Cells

